Use of staphylokinase for the preparation of a pharmaceutical composition for treating arterial thromboisi
US5336495A · kind A · utility
4Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 14, 1993 |
| Grant date | Aug 9, 1994 |
| Priority date | — |
| Expiry date | Jul 14, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/164
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of staphylokinase for the preparation of a pharmaceutical composition for treating arterial thrombosis, such as e.g. myocardial infarction. It is demonstrated that staphylokinase can be particularly useful as a thrombolytic agent for the lysis of platelet-rich clots. Furthermore it is demonstrated that staphylokinase, unlike streptokinase, does not induce antibody induction upon repeated administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.